Fierce Biotech

Subscribe to Fierce Biotech feed
Updated: 15 min 5 sec ago

AstraZeneca puts further $75M up for grabs in expanded Proteros cancer drug deal

Thu, 05/12/2022 - 11:52
AstraZeneca puts further $75M up for grabs in expanded Proteros cancer drug deal gmasson Thu, 05/12/2022 - 14:52

As Siemens AG leaves Russia over Ukraine war, Siemens Healthineers will stay

Thu, 05/12/2022 - 11:31
As Siemens AG leaves Russia over Ukraine war, Siemens Healthineers will stay chale Thu, 05/12/2022 - 14:31

Human Cell Atlas initiative makes strides as scientists piece together 'Google Map' of human cells

Thu, 05/12/2022 - 10:43
Human Cell Atlas initiative makes strides as scientists piece together 'Google Map' of human cells aliu Thu, 05/12/2022 - 13:43

Chutes & Ladders—Moderna CFO Gomez departs after just one day following unearthed investigation

Thu, 05/12/2022 - 10:24
Chutes & Ladders—Moderna CFO Gomez departs after just one day following unearthed investigation mbayer Thu, 05/12/2022 - 13:24

Paige nets European OK for AI to spot prostate cancer biomarkers

Thu, 05/12/2022 - 08:57
Paige nets European OK for AI to spot prostate cancer biomarkers apark Thu, 05/12/2022 - 11:57

GE Healthcare aims to bring prenatal ultrasound to the home, with investment in smartphone-scanner developer

Thu, 05/12/2022 - 08:32
GE Healthcare aims to bring prenatal ultrasound to the home, with investment in smartphone-scanner developer chale Thu, 05/12/2022 - 11:32

Mammogram-reading AI developer Therapixel snags €15M to expand US presence

Thu, 05/12/2022 - 06:59
Mammogram-reading AI developer Therapixel snags €15M to expand US presence apark Thu, 05/12/2022 - 09:59

Abbott, Women as One set up diversity-focused training program​​​

Thu, 05/12/2022 - 06:21
Abbott, Women as One set up diversity-focused training program​​​ aarmstrong Thu, 05/12/2022 - 09:21

Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race

Thu, 05/12/2022 - 05:58
Bristol Myers provides Bridge over troubled water with $905M deal to enter SHP2 race ntaylor Thu, 05/12/2022 - 08:58

After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhom

Thu, 05/12/2022 - 04:47
After 20 years, Boehringer vet hits the exit to become CEO at autoimmune biotech SciRhom ntaylor Thu, 05/12/2022 - 07:47

Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data

Wed, 05/11/2022 - 18:55
Bristol Myers on track for 3rd new drug launch of 2022 with latest deucravacitinib data gmasson Wed, 05/11/2022 - 21:55

Taiho claws back some licensing rights to lung cancer med from Cullinan in atypical, frontloaded deal

Wed, 05/11/2022 - 15:21
Taiho claws back some licensing rights to lung cancer med from Cullinan in atypical, frontloaded deal mbayer Wed, 05/11/2022 - 18:21

Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T results

Wed, 05/11/2022 - 12:19
Caribou ready to uncork the chardonnay thanks to first-in-human CAR-T results aarmstrong Wed, 05/11/2022 - 15:19

Former Immunomedics CFO Usama Malik indicted for insider trading, pledging to dispute 'false and speculative narrative' at trial

Wed, 05/11/2022 - 10:51
Former Immunomedics CFO Usama Malik indicted for insider trading, pledging to dispute 'false and speculative narrative' at trial gmasson Wed, 05/11/2022 - 13:51

FTC orders Medtronic to sell off Intersect ENT subsidiary in antitrust review

Wed, 05/11/2022 - 08:52
FTC orders Medtronic to sell off Intersect ENT subsidiary in antitrust review apark Wed, 05/11/2022 - 11:52

BD, Babson set sights on bringing simple blood collection into the home

Wed, 05/11/2022 - 07:53
BD, Babson set sights on bringing simple blood collection into the home chale Wed, 05/11/2022 - 10:53

Welcome to New (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal

Wed, 05/11/2022 - 07:45
Welcome to New (Bio) Haven: CEO hopes to strike gold twice with remaining R&D crew after Pfizer deal mbayer Wed, 05/11/2022 - 10:45

Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases

Wed, 05/11/2022 - 07:37
Novo Nordisk, Flagship's forward-thinking partnership aims to treat cardiometabolic, rare diseases gmasson Wed, 05/11/2022 - 10:37

Bioasis, Neuramedy to cross blood-brain barrier together in $72M licensing deal

Wed, 05/11/2022 - 07:23
Bioasis, Neuramedy to cross blood-brain barrier together in $72M licensing deal aarmstrong Wed, 05/11/2022 - 10:23

Bioventus nixes $415M funding plan for CartiHeal acquisition, citing 'current market conditions'

Wed, 05/11/2022 - 07:07
Bioventus nixes $415M funding plan for CartiHeal acquisition, citing 'current market conditions' apark Wed, 05/11/2022 - 10:07